APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

General Anesthetic for Surgery

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global General Anesthetic for Surgery Market Outlook and Growth Opportunities 2026

Report ID 173994680422 December 2025194 pages

Choose your research edition.

Industry ResearchGeneral Anesthetic for Surgery Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal General Anesthetic for Surgery Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal General Anesthetic for Surgery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Anesthetic for Surgery Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal General Anesthetic for Surgery Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global General Anesthetic for Surgery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for General Anesthetic for Surgery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the General Anesthetic for Surgery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the General Anesthetic for Surgery market include Yichang Humanwell, Xi'an Libang, Nhwa, Hengrui, Fresenius-Kabi, B.Braun, Baxter Healthcare, AbbVie and Piramal, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global General Anesthetic for Surgery market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of General Anesthetic for Surgery and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents General Anesthetic for Surgery sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the General Anesthetic for Surgery market size, projected growth trends, production technologies, key applications, and end-use industries.

General Anesthetic for Surgery Segment by Company

Yichang Humanwell

Xi'an Libang

Nhwa

Hengrui

Fresenius-Kabi

B.Braun

Baxter Healthcare

AbbVie

Piramal

Maruishi

Hikma Pharmaceuticals

Aspen Pharma

General Anesthetic for Surgery Segment by Type

Isoflurane

Etomidate

Remifentanil

Sevoflurane

Propofol

Other

General Anesthetic for Surgery Segment by Application

Intravenous Anesthetics

Inhalational Anesthetics

General Anesthetic for Surgery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global General Anesthetic for Surgery status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions General Anesthetic for Surgery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify General Anesthetic for Surgery significant trends, drivers, influence factors in global and regions.

6. To analyze General Anesthetic for Surgery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Anesthetic for Surgery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Anesthetic for Surgery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Anesthetic for Surgery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the General Anesthetic for Surgery market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global General Anesthetic for Surgery industry.

Chapter 3: Detailed analysis of General Anesthetic for Surgery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of General Anesthetic for Surgery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of General Anesthetic for Surgery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. General Anesthetic for Surgery Industry Trends Table 2. General Anesthetic for Surgery Industry Drivers Table 3. General Anesthetic for Surgery Industry Opportunities and Challenges Table 4. General Anesthetic for Surgery Industry Restraints Table 5. Global General Anesthetic for Surgery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global General Anesthetic for Surgery Revenue Share by Company (2021-2026) Table 7. Global General Anesthetic for Surgery Sales Volume by Company (k units) & (2021-2026) Table 8. Global General Anesthetic for Surgery Sales Volume Share by Company (2021-2026) Table 9. Global General Anesthetic for Surgery Average Price (US$/unit) of Company (2021-2026) Table 10. Global General Anesthetic for Surgery Company Ranking, (2024-2026) & (USD Million) Table 11. Global General Anesthetic for Surgery Key Company Manufacturing Base & Headquarters Table 12. Global General Anesthetic for Surgery Company, Product Type & Application Table 13. Global General Anesthetic for Surgery Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global General Anesthetic for Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Isoflurane Table 18. Significant Companies of Etomidate Table 19. Significant Companies of Remifentanil Table 20. Significant Companies of Sevoflurane Table 21. Significant Companies of Propofol Table 22. Significant Companies of Other Table 23. Global General Anesthetic for Surgery Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global General Anesthetic for Surgery Sales Volume by Type (2021-2026) & (k units) Table 25. Global General Anesthetic for Surgery Sales Volume by Type (2027-2032) & (k units) Table 26. Global General Anesthetic for Surgery Sales Volume Share by Type (2021-2026) Table 27. Global General Anesthetic for Surgery Sales Volume Share by Type (2027-2032) Table 28. Global General Anesthetic for Surgery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global General Anesthetic for Surgery Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global General Anesthetic for Surgery Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global General Anesthetic for Surgery Sales Value Share by Type (2021-2026) Table 32. Global General Anesthetic for Surgery Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Intravenous Anesthetics Table 34. Significant Companies of Inhalational Anesthetics Table 35. Global General Anesthetic for Surgery Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global General Anesthetic for Surgery Sales Volume by Application (2021-2026) & (k units) Table 37. Global General Anesthetic for Surgery Sales Volume by Application (2027-2032) & (k units) Table 38. Global General Anesthetic for Surgery Sales Volume Share by Application (2021-2026) Table 39. Global General Anesthetic for Surgery Sales Volume Share by Application (2027-2032) Table 40. Global General Anesthetic for Surgery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global General Anesthetic for Surgery Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global General Anesthetic for Surgery Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global General Anesthetic for Surgery Sales Value Share by Application (2021-2026) Table 44. Global General Anesthetic for Surgery Sales Value Share by Application (2027-2032) Table 45. Global General Anesthetic for Surgery Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global General Anesthetic for Surgery Sales by Region (2021-2026) & (k units) Table 47. Global General Anesthetic for Surgery Sales Market Share by Region (2021-2026) Table 48. Global General Anesthetic for Surgery Sales by Region (2027-2032) & (k units) Table 49. Global General Anesthetic for Surgery Sales Market Share by Region (2027-2032) Table 50. Global General Anesthetic for Surgery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global General Anesthetic for Surgery Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global General Anesthetic for Surgery Sales Value Share by Region (2021-2026) Table 53. Global General Anesthetic for Surgery Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global General Anesthetic for Surgery Sales Value Share by Region (2027-2032) Table 55. Global General Anesthetic for Surgery Market Average Price (US$/unit) by Region (2021-2026) Table 56. Global General Anesthetic for Surgery Market Average Price (US$/unit) by Region (2027-2032) Table 57. Global General Anesthetic for Surgery Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global General Anesthetic for Surgery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global General Anesthetic for Surgery Sales by Country (2021-2026) & (k units) Table 60. Global General Anesthetic for Surgery Sales Market Share by Country (2021-2026) Table 61. Global General Anesthetic for Surgery Sales by Country (2027-2032) & (k units) Table 62. Global General Anesthetic for Surgery Sales Market Share by Country (2027-2032) Table 63. Global General Anesthetic for Surgery Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global General Anesthetic for Surgery Sales Value Market Share by Country (2021-2026) Table 65. Global General Anesthetic for Surgery Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global General Anesthetic for Surgery Sales Value Market Share by Country (2027-2032) Table 67. Yichang Humanwell Company Information Table 68. Yichang Humanwell Business Overview Table 69. Yichang Humanwell General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Yichang Humanwell General Anesthetic for Surgery Product Portfolio Table 71. Yichang Humanwell Recent Development Table 72. Xi'an Libang Company Information Table 73. Xi'an Libang Business Overview Table 74. Xi'an Libang General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Xi'an Libang General Anesthetic for Surgery Product Portfolio Table 76. Xi'an Libang Recent Development Table 77. Nhwa Company Information Table 78. Nhwa Business Overview Table 79. Nhwa General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Nhwa General Anesthetic for Surgery Product Portfolio Table 81. Nhwa Recent Development Table 82. Hengrui Company Information Table 83. Hengrui Business Overview Table 84. Hengrui General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Hengrui General Anesthetic for Surgery Product Portfolio Table 86. Hengrui Recent Development Table 87. Fresenius-Kabi Company Information Table 88. Fresenius-Kabi Business Overview Table 89. Fresenius-Kabi General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Fresenius-Kabi General Anesthetic for Surgery Product Portfolio Table 91. Fresenius-Kabi Recent Development Table 92. B.Braun Company Information Table 93. B.Braun Business Overview Table 94. B.Braun General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. B.Braun General Anesthetic for Surgery Product Portfolio Table 96. B.Braun Recent Development Table 97. Baxter Healthcare Company Information Table 98. Baxter Healthcare Business Overview Table 99. Baxter Healthcare General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Baxter Healthcare General Anesthetic for Surgery Product Portfolio Table 101. Baxter Healthcare Recent Development Table 102. AbbVie Company Information Table 103. AbbVie Business Overview Table 104. AbbVie General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. AbbVie General Anesthetic for Surgery Product Portfolio Table 106. AbbVie Recent Development Table 107. Piramal Company Information Table 108. Piramal Business Overview Table 109. Piramal General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Piramal General Anesthetic for Surgery Product Portfolio Table 111. Piramal Recent Development Table 112. Maruishi Company Information Table 113. Maruishi Business Overview Table 114. Maruishi General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Maruishi General Anesthetic for Surgery Product Portfolio Table 116. Maruishi Recent Development Table 117. Hikma Pharmaceuticals Company Information Table 118. Hikma Pharmaceuticals Business Overview Table 119. Hikma Pharmaceuticals General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio Table 121. Hikma Pharmaceuticals Recent Development Table 122. Aspen Pharma Company Information Table 123. Aspen Pharma Business Overview Table 124. Aspen Pharma General Anesthetic for Surgery Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Aspen Pharma General Anesthetic for Surgery Product Portfolio Table 126. Aspen Pharma Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. General Anesthetic for Surgery Distributors List Table 130. General Anesthetic for Surgery Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. General Anesthetic for Surgery Product Image Figure 2. Global General Anesthetic for Surgery Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Anesthetic for Surgery Sales Value (2021-2032) & (US$ Million) Figure 4. Global General Anesthetic for Surgery Sales (2021-2032) & (k units) Figure 5. Global General Anesthetic for Surgery Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global General Anesthetic for Surgery Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Isoflurane Image Figure 10. Etomidate Image Figure 11. Remifentanil Image Figure 12. Sevoflurane Image Figure 13. Propofol Image Figure 14. Other Image Figure 15. Global General Anesthetic for Surgery Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global General Anesthetic for Surgery Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global General Anesthetic for Surgery Sales Volume Share by Type (2021-2032) Figure 18. Global General Anesthetic for Surgery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global General Anesthetic for Surgery Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global General Anesthetic for Surgery Sales Value Share by Type (2021-2032) Figure 21. Intravenous Anesthetics Image Figure 22. Inhalational Anesthetics Image Figure 23. Global General Anesthetic for Surgery Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global General Anesthetic for Surgery Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global General Anesthetic for Surgery Sales Volume Share by Application (2021-2032) Figure 26. Global General Anesthetic for Surgery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global General Anesthetic for Surgery Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global General Anesthetic for Surgery Sales Value Share by Application (2021-2032) Figure 29. Global General Anesthetic for Surgery Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global General Anesthetic for Surgery Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global General Anesthetic for Surgery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global General Anesthetic for Surgery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America General Anesthetic for Surgery Sales Value (2021-2032) & (US$ Million) Figure 34. North America General Anesthetic for Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe General Anesthetic for Surgery Sales Value (2021-2032) & (US$ Million) Figure 36. Europe General Anesthetic for Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific General Anesthetic for Surgery Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific General Anesthetic for Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America General Anesthetic for Surgery Sales Value (2021-2032) & (US$ Million) Figure 40. South America General Anesthetic for Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa General Anesthetic for Surgery Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa General Anesthetic for Surgery Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt General Anesthetic for Surgery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. General Anesthetic for Surgery Value Chain Figure 128. Manufacturing Cost Structure Figure 129. General Anesthetic for Surgery Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Etomidate
  • Remifentanil
  • Sevoflurane
  • Propofol
  • Other
Applications
  • Intravenous Anesthetics
  • Inhalational Anesthetics
Companies covered
  • Yichang Humanwell
  • Xi'an Libang
  • Nhwa
  • Hengrui
  • Fresenius-Kabi
  • B.Braun
  • Baxter Healthcare
  • AbbVie
  • Piramal
  • Maruishi
  • Hikma Pharmaceuticals
  • Aspen Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global General Anesthetic for Surgery Sales Value (2021-2032)
  4. 1.2.2 Global General Anesthetic for Surgery Sales Volume (2021-2032)
  5. 1.2.3 Global General Anesthetic for Surgery Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 General Anesthetic for Surgery Market Dynamics
  1. 2.1 General Anesthetic for Surgery Industry Trends
  2. 2.2 General Anesthetic for Surgery Industry Drivers
  3. 2.3 General Anesthetic for Surgery Industry Opportunities and Challenges
  4. 2.4 General Anesthetic for Surgery Industry Restraints
3 General Anesthetic for Surgery Market by Company
  1. 3.1 Global General Anesthetic for Surgery Company Revenue Ranking in 2025
  2. 3.2 Global General Anesthetic for Surgery Revenue by Company (2021-2026)
  3. 3.3 Global General Anesthetic for Surgery Sales Volume by Company (2021-2026)
  4. 3.4 Global General Anesthetic for Surgery Average Price by Company (2021-2026)
  5. 3.5 Global General Anesthetic for Surgery Company Ranking (2024-2026)
  6. 3.6 Global General Anesthetic for Surgery Company Manufacturing Base and Headquarters
  7. 3.7 Global General Anesthetic for Surgery Company Product Type and Application
  8. 3.8 Global General Anesthetic for Surgery Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global General Anesthetic for Surgery Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 General Anesthetic for Surgery Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 General Anesthetic for Surgery Market by Type
  1. 4.1 General Anesthetic for Surgery Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Etomidate
  4. 4.1.3 Remifentanil
  5. 4.1.4 Sevoflurane
  6. 4.1.5 Propofol
  7. 4.1.6 Other
  8. 4.2 Global General Anesthetic for Surgery Sales Volume by Type
  9. 4.2.1 Global General Anesthetic for Surgery Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global General Anesthetic for Surgery Sales Volume by Type (2021-2032)
  11. 4.2.3 Global General Anesthetic for Surgery Sales Volume Share by Type (2021-2032)
  12. 4.3 Global General Anesthetic for Surgery Sales Value by Type
  13. 4.3.1 Global General Anesthetic for Surgery Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global General Anesthetic for Surgery Sales Value by Type (2021-2032)
  15. 4.3.3 Global General Anesthetic for Surgery Sales Value Share by Type (2021-2032)
5 General Anesthetic for Surgery Market by Application
  1. 5.1 General Anesthetic for Surgery Application Introduction
  2. 5.1.1 Intravenous Anesthetics
  3. 5.1.2 Inhalational Anesthetics
  4. 5.2 Global General Anesthetic for Surgery Sales Volume by Application
  5. 5.2.1 Global General Anesthetic for Surgery Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global General Anesthetic for Surgery Sales Volume by Application (2021-2032)
  7. 5.2.3 Global General Anesthetic for Surgery Sales Volume Share by Application (2021-2032)
  8. 5.3 Global General Anesthetic for Surgery Sales Value by Application
  9. 5.3.1 Global General Anesthetic for Surgery Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global General Anesthetic for Surgery Sales Value by Application (2021-2032)
  11. 5.3.3 Global General Anesthetic for Surgery Sales Value Share by Application (2021-2032)
6 General Anesthetic for Surgery Regional Sales and Value Analysis
  1. 6.1 Global General Anesthetic for Surgery Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global General Anesthetic for Surgery Sales by Region (2021-2032)
  3. 6.2.1 Global General Anesthetic for Surgery Sales by Region: 2021-2026
  4. 6.2.2 Global General Anesthetic for Surgery Sales by Region (2027-2032)
  5. 6.3 Global General Anesthetic for Surgery Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global General Anesthetic for Surgery Sales Value by Region (2021-2032)
  7. 6.4.1 Global General Anesthetic for Surgery Sales Value by Region: 2021-2026
  8. 6.4.2 Global General Anesthetic for Surgery Sales Value by Region (2027-2032)
  9. 6.5 Global General Anesthetic for Surgery Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America General Anesthetic for Surgery Sales Value (2021-2032)
  12. 6.6.2 North America General Anesthetic for Surgery Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe General Anesthetic for Surgery Sales Value (2021-2032)
  15. 6.7.2 Europe General Anesthetic for Surgery Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific General Anesthetic for Surgery Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific General Anesthetic for Surgery Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America General Anesthetic for Surgery Sales Value (2021-2032)
  21. 6.9.2 South America General Anesthetic for Surgery Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa General Anesthetic for Surgery Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa General Anesthetic for Surgery Sales Value Share by Country, 2025 VS 2032
7 General Anesthetic for Surgery Country-level Sales and Value Analysis
  1. 7.1 Global General Anesthetic for Surgery Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global General Anesthetic for Surgery Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global General Anesthetic for Surgery Sales by Country (2021-2032)
  4. 7.3.1 Global General Anesthetic for Surgery Sales by Country (2021-2026)
  5. 7.3.2 Global General Anesthetic for Surgery Sales by Country (2027-2032)
  6. 7.4 Global General Anesthetic for Surgery Sales Value by Country (2021-2032)
  7. 7.4.1 Global General Anesthetic for Surgery Sales Value by Country (2021-2026)
  8. 7.4.2 Global General Anesthetic for Surgery Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt General Anesthetic for Surgery Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt General Anesthetic for Surgery Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt General Anesthetic for Surgery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Humanwell
  2. 8.1.1 Yichang Humanwell Company Information
  3. 8.1.2 Yichang Humanwell Business Overview
  4. 8.1.3 Yichang Humanwell General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Humanwell General Anesthetic for Surgery Product Portfolio
  6. 8.1.5 Yichang Humanwell Recent Developments
  7. 8.2 Xi'an Libang
  8. 8.2.1 Xi'an Libang Company Information
  9. 8.2.2 Xi'an Libang Business Overview
  10. 8.2.3 Xi'an Libang General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Libang General Anesthetic for Surgery Product Portfolio
  12. 8.2.5 Xi'an Libang Recent Developments
  13. 8.3 Nhwa
  14. 8.3.1 Nhwa Company Information
  15. 8.3.2 Nhwa Business Overview
  16. 8.3.3 Nhwa General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nhwa General Anesthetic for Surgery Product Portfolio
  18. 8.3.5 Nhwa Recent Developments
  19. 8.4 Hengrui
  20. 8.4.1 Hengrui Company Information
  21. 8.4.2 Hengrui Business Overview
  22. 8.4.3 Hengrui General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hengrui General Anesthetic for Surgery Product Portfolio
  24. 8.4.5 Hengrui Recent Developments
  25. 8.5 Fresenius-Kabi
  26. 8.5.1 Fresenius-Kabi Company Information
  27. 8.5.2 Fresenius-Kabi Business Overview
  28. 8.5.3 Fresenius-Kabi General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Fresenius-Kabi General Anesthetic for Surgery Product Portfolio
  30. 8.5.5 Fresenius-Kabi Recent Developments
  31. 8.6 B.Braun
  32. 8.6.1 B.Braun Company Information
  33. 8.6.2 B.Braun Business Overview
  34. 8.6.3 B.Braun General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 B.Braun General Anesthetic for Surgery Product Portfolio
  36. 8.6.5 B.Braun Recent Developments
  37. 8.7 Baxter Healthcare
  38. 8.7.1 Baxter Healthcare Company Information
  39. 8.7.2 Baxter Healthcare Business Overview
  40. 8.7.3 Baxter Healthcare General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Baxter Healthcare General Anesthetic for Surgery Product Portfolio
  42. 8.7.5 Baxter Healthcare Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie General Anesthetic for Surgery Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 Piramal
  50. 8.9.1 Piramal Company Information
  51. 8.9.2 Piramal Business Overview
  52. 8.9.3 Piramal General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Piramal General Anesthetic for Surgery Product Portfolio
  54. 8.9.5 Piramal Recent Developments
  55. 8.10 Maruishi
  56. 8.10.1 Maruishi Company Information
  57. 8.10.2 Maruishi Business Overview
  58. 8.10.3 Maruishi General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Maruishi General Anesthetic for Surgery Product Portfolio
  60. 8.10.5 Maruishi Recent Developments
  61. 8.11 Hikma Pharmaceuticals
  62. 8.11.1 Hikma Pharmaceuticals Company Information
  63. 8.11.2 Hikma Pharmaceuticals Business Overview
  64. 8.11.3 Hikma Pharmaceuticals General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hikma Pharmaceuticals General Anesthetic for Surgery Product Portfolio
  66. 8.11.5 Hikma Pharmaceuticals Recent Developments
  67. 8.12 Aspen Pharma
  68. 8.12.1 Aspen Pharma Company Information
  69. 8.12.2 Aspen Pharma Business Overview
  70. 8.12.3 Aspen Pharma General Anesthetic for Surgery Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Aspen Pharma General Anesthetic for Surgery Product Portfolio
  72. 8.12.5 Aspen Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 General Anesthetic for Surgery Value Chain Analysis
  2. 9.1.1 General Anesthetic for Surgery Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 General Anesthetic for Surgery Sales Mode & Process
  6. 9.2 General Anesthetic for Surgery Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 General Anesthetic for Surgery Distributors
  9. 9.2.3 General Anesthetic for Surgery Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst